Standard Biotools Inc (LAB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Standard Biotools Inc-Aktie (LAB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.16% 19.55	21.76	40.80	46.72	44.97
Cost Of Revenue	9.57% 10.07	11.13	21.05	24.81	21.71
Gross Profit	10.76% 9.484	10.63	19.74	21.91	23.26
Operating Expenses	16.78% 42.42	36.33	52.71	54.72	54.98
Benefits Costs and Expenses	30.99% 52.45	40.04	66.98	80.52	71.79
Costs And Expenses	30.99% 52.45	40.04	66.98	80.52	71.79
Operating Income/Loss	28.18% -32.94	-25.70	-32.97	-32.82	-31.72
Income/Loss From Continuing Operations Before Tax	79.96% -32.90	-18.28	-26.18	-33.80	-26.82
Income Tax Expense/Benefit	99.67% -1.216	-0.609	-0.151	0.272	0.118
Income/Loss From Continuing Operations After Tax	79.28% -31.68	-17.67	-26.03	-34.07	-26.94
Income/Loss From Discontinued Operations, Net Of Tax	80.98% -3.003	-15.79	-2.663	-	-
Net Income/Loss	3.67% -34.69	-33.46	-26.03	-34.07	-26.94
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.56% 382.63	380.50	378.23	7.152	371.54
Diluted Average Shares	0.56% 382.63	380.50	378.23	7.152	371.54
Basic Earnings Per Share	0.00% -0.09	-0.09	-0.07	-0.08	-0.07
Diluted Earnings Per Share	0.00% -0.09	-0.09	-0.07	-0.08	-0.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ZBH

$93.20

0.66%

STE

$214.57

1.05%

DXCM

$64.24

1.56%

PHG

$27.79

1.66%

GEHC

$70.77

0.63%

$81.81

3.31%